XOMA News and Press, XOMA Corporation From 03/10/22

EMERYVILLE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improving human health, announced today its Chairman and Chief Executive Officer, Jim Neal, will p...

XOMA press release (NASDAQ:XOMA): Q4 GAAP EPS of $1.67 misses by $0.60. Revenue of $35.94M (+30.2% Y/Y) beats by $0.8M. Ended 2021 with cash and restricted cash of $95.4 million and no debt on the company’s balance sheet For further details see: XOMA GAAP EPS of $1.67 misses by $...

Earned $35 million milestone payment as NIS793 entered Phase 3 clinical study in metastatic pancreatic cancer Received $1.2 million from three milestone payments, two of which were from a single Janssen asset and one was from Compugen Earned a $2 million milestone from...

EMERYVILLE, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improving human health, announced today its Chairman and Chief Executive Officer, Jim Neal, will b...

EMERYVILLE, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improving human health, announced today its Chief Executive Officer, Jim Neal, will present at the ...

Investing in the biotech industry is an art, not a science. While the potential for gains from groundbreaking therapies exists, the majority fail. By utilizing statistics, careful selection, and net present value calculations, it is quite easy to find a basket that fulfills your p...

XOMA Corporation (NASDAQ:XOMA) appoints CEO Jim Neal as Chairman of the Board, succeeding W. Denman (Denny) Van Ness who will continue as lead independent Director. Mr. Neal will retire from his operational role as CEO at such time as his successor has been appointed. The ...

Chief Executive Officer Jim Neal appointed as Chairman; Former Chairman W. Denman Van Ness to remain Lead Independent Director Company is launching Chief Executive Officer search; Jim Neal will retire from CEO role when successor has been appointed EMERYVILLE, Calif., Dec. 1...

XOMA (NASDAQ:XOMA): Q3 GAAP EPS of -$0.51 misses by $0.31. Revenue of $0.9M (+50.0% Y/Y) misses by $1.6M. Press Release For further details see: XOMA EPS misses by $0.31, misses on revenue

EMERYVILLE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) announced today NIS793, an anti-TGFβ monoclonal antibody licensed from the Company, has advanced to the Phase 3 development stage, triggering a $35 million milestone payment from Novartis.  The...